Study Comparing Imiquimod Cream, 3.75% to Zyclara® (Imiquimod) Cream, 3.75% in the Treatment of Actinic Keratosis
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01686152 |
Recruitment Status
:
Completed
First Posted
: September 17, 2012
Last Update Posted
: December 6, 2013
|
Sponsor:
Teva Pharmaceuticals USA
Information provided by (Responsible Party):
Teva Pharmaceuticals USA
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : | Completed |
---|---|
Actual Primary Completion Date : | August 2013 |
Actual Study Completion Date : | August 2013 |